News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Elan Corporation PLC May Spin Off Contract Manufacturing Arm
May 27, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Irish drugmaker Elan is considering a separate stock exchange listing for its contract services unit, Elan Drug Technology, according to comments by executives at its recent annual general meeting.
Twitter
LinkedIn
Facebook
Email
Print
Startups
Europe
MORE ON THIS TOPIC
Mergers & acquisitions
UPDATE: Avadel Accepts Alkermes’ Revised $2.37B Counteroffer, Besting Lundbeck
November 19, 2025
·
3 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Genmab Prunes Another ADC From $1.8B ProfoundBio Acquisition
November 18, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Nxera’s Quest for Profitability Claims 15% of Workforce
November 18, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
J&J, Aiming for $50B in Cancer Sales, Buys Halda for $3B in Cash
November 17, 2025
·
2 min read
·
Dan Samorodnitsky
